Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 250310, 13 pages
http://dx.doi.org/10.1155/2015/250310
Review Article

Inhibition of Adenylyl Cyclase Type 5 Increases Longevity and Healthful Aging through Oxidative Stress Protection

Departments of Cell Biology & Molecular Medicine and Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA

Received 2 January 2015; Revised 10 March 2015; Accepted 13 March 2015

Academic Editor: Vincent Pialoux

Copyright © 2015 Stephen F. Vatner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Okumura, G. Takagi, J.-I. Kawabe et al., “Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 17, pp. 9986–9990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Okumura, D. E. Vatner, R. Kurotani et al., “Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress,” Circulation, vol. 116, no. 16, pp. 1776–1783, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lai, L. Yan, S. Gao et al., “Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway,” Circulation, vol. 127, no. 16, pp. 1692–1701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Yan, D. E. Vatner, J. P. O'Connor et al., “Type 5 adenylyl cyclase disruption increases longevity and protects against stress,” Cell, vol. 130, no. 2, pp. 247–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. F. Vatner, M. Park, L. Yan et al., “Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, pp. H1–H8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Yan, J. Y. Park, J.-G. Dillinger et al., “Common mechanisms for calorie restriction and adenylyl cyclase type 5 knockout models of longevity,” Aging Cell, vol. 11, no. 6, pp. 1110–1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. P. Weiss, S. B. Racette, D. T. Villareal et al., “Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss,” Journal of Applied Physiology, vol. 102, no. 2, pp. 634–640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Faulks, N. Turner, P. L. Else, and A. J. Hulbert, “Calorie restriction in mice: effects on body composition, daily activity, metabolic rate, mitochondrial reactive oxygen species production, and membrane fatty acid composition,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 61, no. 8, pp. 781–794, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Flurkey, J. Papaconstantinou, R. A. Miller, and D. E. Harrison, “Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6736–6741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Holzenberger, J. Dupont, B. Ducos et al., “IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice,” Nature, vol. 421, no. 6919, pp. 182–187, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Kurosu, M. Yamamoto, J. D. Clark et al., “Suppression of aging in mice by the hormone Klotho,” Science, vol. 309, no. 5742, pp. 1829–1833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Yamamoto, J. D. Clark, J. V. Pastor et al., “Regulation of oxidative stress by the anti-aging hormone klotho,” The Journal of Biological Chemistry, vol. 280, no. 45, pp. 38029–38034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Migliaccio, M. Giogio, S. Mele et al., “The p66shc adaptor protein controls oxidative stress response and life span in mammals,” Nature, vol. 402, no. 6759, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Mitsui, J. Hamuro, H. Nakamura et al., “Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span,” Antioxidants and Redox Signaling, vol. 4, no. 4, pp. 693–696, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Schriner, N. J. Linford, G. M. Martin et al., “Extension of murine life span by overexpression of catalase targeted to mitochondria,” Science, vol. 308, no. 5730, pp. 1909–1911, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Yang, T. A. Doser, C. X. Fang et al., “Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress,” The FASEB Journal, vol. 20, no. 7, pp. 1024–1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Benigni, D. Corna, C. Zoja et al., “Disruption of the Ang II type 1 receptor promotes longevity in mice,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 524–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Selman, S. Lingard, A. I. Choudhury et al., “Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice,” The FASEB Journal, vol. 22, no. 3, pp. 807–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Sadagurski, Z. Cheng, A. Rozzo et al., “IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease,” Journal of Clinical Investigation, vol. 121, no. 10, pp. 4070–4081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Miller, G. Buehner, Y. Chang, J. M. Harper, R. Sigler, and M. Smith-Wheelock, “Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance,” Aging Cell, vol. 4, no. 3, pp. 119–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Dell'Agnello, S. Leo, A. Agostino et al., “Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice,” Human Molecular Genetics, vol. 16, no. 4, pp. 431–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Bartke, “New findings in gene knockout, mutant and transgenic mice,” Experimental Gerontology, vol. 43, no. 1, pp. 11–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-H. Wei and H.-C. Lee, “Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging,” Experimental Biology and Medicine, vol. 227, no. 9, pp. 671–682, 2002. View at Google Scholar · View at Scopus
  24. V. Gambino, G. de Michele, O. Venezia et al., “Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging,” Aging Cell, vol. 12, no. 3, pp. 435–445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ikeyama, G. Kokkonen, S. Shack, X.-T. Wang, and N. J. Holbrook, “Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities,” The FASEB Journal, vol. 16, no. 1, pp. 114–116, 2002. View at Google Scholar · View at Scopus
  26. J. Sastre, F. V. Pallardó, and J. Viña, “The role of mitochondrial oxidative stress in aging,” Free Radical Biology & Medicine, vol. 35, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. F. G. Slater, C. Stefan, I. Nobel, D. J. Van Den Dobbelsteen, and S. Orrenius, “Signalling mechanisms and oxidative stress in apoptosis,” Toxicology Letters, vol. 82-83, pp. 149–153, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Ran, H. Liang, Y. Ikeno et al., “Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis,” The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 62, no. 9, pp. 932–942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Csiszar, N. Labinskyy, V. Perez et al., “Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 5, pp. H1882–H1894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. L. Heiman, F. C. Tinsley, J. A. Mattison, S. Hauck, and A. Bartke, “Body composition of prolactin-, growth hormone-, and thyrotropin-deficient Ames dwarf mice,” Endocrine, vol. 20, no. 1-2, pp. 149–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Sanz, A. Bartke, and G. Barja, “Long-lived ames dwarf mice: oxidative damage to mitochondrial DNA in heart and brain,” Journal of the American Aging Association, vol. 25, no. 3, pp. 119–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Qiu, K. Brown, M. D. Hirschey, E. Verdin, and D. Chen, “Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation,” Cell Metabolism, vol. 12, no. 6, pp. 662–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. A. Sinclair, “Toward a unified theory of caloric restriction and longevity regulation,” Mechanisms of Ageing and Development, vol. 126, no. 9, pp. 987–1002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Dhahbi, P. L. Mote, J. Wingo et al., “Caloric restriction alters the feeding response of key metabolic enzyme genes,” Mechanisms of Ageing and Development, vol. 122, no. 10, pp. 1033–1048, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Weindruch, R. L. Walford, S. Fligiel, and D. Guthrie, “The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake,” The Journal of Nutrition, vol. 116, no. 4, pp. 641–654, 1986. View at Google Scholar · View at Scopus
  36. K. T. Coschigano, D. Clemmons, L. L. Bellush, and J. J. Kopchick, “Assessment of growth parameters and life span of GHR/BP gene-disrupted mice,” Endocrinology, vol. 141, no. 7, pp. 2608–2613, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. S. J. Hauck, J. M. Aaron, C. Wright, J. J. Kopchick, and A. Bartke, “Antioxidant enzymes, free-radical damage, and response to paraquat in liver and kidney of long-living growth hormone receptor/binding protein gene-disrupted mice,” Hormone and Metabolic Research, vol. 34, no. 9, pp. 481–486, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Blüher, B. B. Kahn, and C. R. Kahn, “Extended longevity in mice lacking the insulin receptor in adipose tissue,” Science, vol. 299, no. 5606, pp. 572–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. H. M. Brown-Borg, “Longevity in mice: is stress resistance a common factor?” Age, vol. 28, no. 2, pp. 145–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. B. Salmon, S. Murakami, A. Bartke, J. Kopchick, K. Yasumura, and R. A. Miller, “Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 289, no. 1, pp. E23–E29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Flurkey, J. Papaconstantinou, and D. E. Harrison, “The Snell dwarf mutation Pitdw can increase life span in mice,” Mechanisms of Ageing and Development, vol. 123, no. 2-3, pp. 121–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Murakami, A. Salmon, and R. A. Miller, “Multiplex stress resistance in cells from long-lived dwarf mice,” The FASEB Journal, vol. 17, no. 11, pp. 1565–1566, 2003. View at Google Scholar · View at Scopus
  43. J. M. Harper, J. E. Wilkinson, and R. A. Miller, “Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction,” The FASEB Journal, vol. 24, no. 7, pp. 2436–2442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Koga, A. Kenessey, S. R. Powell, C. P. Sison, E. J. Miller, and K. Ojamaa, “Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress,” Antioxidants & Redox Signaling, vol. 14, no. 7, pp. 1191–1202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Conover and L. K. Bale, “Loss of pregnancy-associated plasma protein A extends lifespan in mice,” Aging Cell, vol. 6, no. 5, pp. 727–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. A. Conover, L. K. Bale, M. T. Overgaard et al., “Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development,” Development, vol. 131, no. 5, pp. 1187–1194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Miskin, O. Tirosh, M. Pardo et al., “AlphaMUPA mice: a transgenic model for longevity induced by caloric restriction,” Mechanisms of Ageing and Development, vol. 126, no. 2, pp. 255–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Tirosh, M. Pardo, B. Schwartz, and R. Miskin, “Long-lived αMUPA transgenic mice show reduced SOD2 expression, enhanced apoptosis and reduced susceptibility to the carcinogen dimethylhydrazine,” Mechanisms of Ageing and Development, vol. 126, no. 12, pp. 1262–1273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. L. C. Enns, J. F. Morton, P. R. Treuting et al., “Disruption of protein kinase A in mice enhances healthy aging,” PLoS ONE, vol. 4, no. 6, Article ID e5963, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. F. Bokov, N. Garg, Y. Ikeno et al., “Does reduced IGF-1R signaling in igf1r+/- mice alter aging?” PLoS ONE, vol. 6, no. 11, Article ID e26891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Liang, E. J. Masoro, J. F. Nelson, R. Strong, C. A. McMahan, and A. Richardson, “Genetic mouse models of extended lifespan,” Experimental Gerontology, vol. 38, no. 11-12, pp. 1353–1364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Selman, J. M. A. Tullet, D. Wieser et al., “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span,” Science, vol. 326, no. 5949, pp. 140–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. H. Um, F. Frigerio, M. Watanabe et al., “Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity,” Nature, vol. 431, pp. 200–205, 2004. View at Publisher · View at Google Scholar
  54. A. Bartke, “Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging,” Trends in Endocrinology and Metabolism, vol. 17, no. 2, pp. 33–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Conti, M. Sanchez-Alavez, R. Winsky-Sommerer et al., “Transgenic mice with a reduced core body temperature have an increased life span,” Science, vol. 314, no. 5800, pp. 825–828, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Trinei, M. Giorgio, A. Cicalese et al., “A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis,” Oncogene, vol. 21, no. 24, pp. 3872–3878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Hakimi, J. Yang, G. Casadesus et al., “Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse,” The Journal of Biological Chemistry, vol. 282, no. 45, pp. 32844–32855, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Hotta, F. Tashiro, H. Ikegami et al., “Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes,” The Journal of Experimental Medicine, vol. 188, no. 8, pp. 1445–1451, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Ortega-Molina, A. Efeyan, E. Lopez-Guadamillas et al., “Pten positively regulates brown adipose function, energy expenditure, and longevity,” Cell Metabolism, vol. 15, no. 3, pp. 382–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. D.-F. Dai, L. F. Santana, M. Vermulst et al., “Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging,” Circulation, vol. 119, no. 21, pp. 2789–2797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. D. L. Johannsen and E. Ravussin, “Can increased muscle ros scavenging keep older animals young and metabolically fit?” Cell Metabolism, vol. 12, no. 6, pp. 557–558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. P. M. Treuting, N. J. Linford, S. E. Knoblaugh et al., “Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria,” The Journals of Gerontology, Series A, Biological Sciences and Medical Sciences, vol. 63, no. 8, pp. 813–824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Kanfi, S. Naiman, G. Amir et al., “The sirtuin SIRT6 regulates lifespan in male mice,” Nature, vol. 483, no. 7388, pp. 218–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. A. L. Lin, D. A. Pulliam, S. S. Deepa et al., “Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 10, pp. 1605–1611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Lapointe and S. Hekimi, “Early mitochondrial dysfunction in long-lived Mclk1+/- mice,” Journal of Biological Chemistry, vol. 283, no. 38, pp. 26217–26227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Lapointe, Z. Stepanyan, E. Bigras, and S. Hekimi, “Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived Mclk1+/- mice,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20364–20374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. N. S. Dhalla, R. M. Temsah, and T. Netticadan, “Role of oxidative stress in cardiovascular diseases,” Journal of Hypertension, vol. 18, no. 6, pp. 655–673, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. I. Rahman, “The role of oxidative stress in the pathogenesis of COPD: implications for therapy,” Treatments in Respiratory Medicine, vol. 4, no. 3, pp. 175–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. M. H. El Kossi and M. M. Zakhary, “Oxidative stress in the context of acute cerebrovascular stroke,” Stroke, vol. 31, no. 8, pp. 1889–1892, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. W. R. Markesbery, “Oxidative stress hypothesis in Alzheimer's disease,” Free Radical Biology & Medicine, vol. 23, no. 1, pp. 134–147, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. U. Karunakaran and K.-G. Park, “A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense,” Diabetes & Metabolism Journal, vol. 37, no. 2, pp. 106–112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. B. P. Oberg, E. McMenamin, F. L. Lucas et al., “Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease,” Kidney International, vol. 65, no. 3, pp. 1009–1016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. C. F. Brayton, P. M. Treuting, and J. M. Ward, “Pathobiology of aging mice and GEM: background strains and experimental design,” Veterinary Pathology, vol. 49, no. 1, pp. 85–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. J. K. Sinha, S. Ghosh, and M. Raghunath, “Progeria: a rare genetic premature ageing disorder,” The Indian Journal of Medical Research, vol. 139, pp. 667–674, 2014. View at Google Scholar
  76. B. S. Berlett and E. R. Stadtman, “Protein oxidation in aging, disease, and oxidative stress,” The Journal of Biological Chemistry, vol. 272, no. 33, pp. 20313–20316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Lattanzi, S. Marmiroli, A. Facchini, and N. M. Maraldi, “Nuclear damages and oxidative stress: new perspectives for laminopathies,” European Journal of Histochemistry, vol. 56, article e45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. M. S. Kane, M. E. Lindsay, D. P. Judge et al., “LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset,” American Journal of Medical Genetics Part A, vol. 161, no. 7, pp. 1599–1611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Gremeaux, M. Gayda, R. Lepers, P. Sosner, M. Juneau, and A. Nigam, “Exercise and longevity,” Maturitas, vol. 73, no. 4, pp. 312–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Goto, Y. Higashi, M. Kimura et al., “Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress,” Circulation, vol. 108, no. 5, pp. 530–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Kruk and E. Duchnik, “Oxidative stress and skin diseases: possible role of physical activity,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 561–568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. R. C. M. Burneiko, Y. S. Diniz, C. M. Galhardi et al., “Interaction of hypercaloric diet and physical exercise on lipid profile, oxidative stress and antioxidant defenses,” Food and Chemical Toxicology, vol. 44, no. 7, pp. 1167–1172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. U. Laufs, S. Wassmann, T. Czech et al., “Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 4, pp. 809–814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Ho, X. Zhao, L. Yan et al., “Adenylyl cyclase type 5 deficiency protects against diet-induced obesity and insulin resistance,” Diabetes, 2015. View at Publisher · View at Google Scholar
  85. A. Fernández-Sánchez, E. Madrigal-Santillán, M. Bautista et al., “Inflammation, oxidative stress, and obesity,” International Journal of Molecular Sciences, vol. 12, no. 5, pp. 3117–3132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Ozata, M. Mergen, C. Oktenli et al., “Increased oxidative stress and hypozincemia in male obesity,” Clinical Biochemistry, vol. 35, no. 8, pp. 627–631, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., “Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Romero-Alvira, E. Roche, and L. Placer, “Cardiomyopathies and oxidative stress,” Medical Hypotheses, vol. 47, no. 2, pp. 137–144, 1996. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Cesselli, I. Jakoniuk, L. Barlucchi et al., “Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy,” Circulation Research, vol. 89, no. 3, pp. 279–286, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Narula, P. Pandey, E. Arbustini et al., “Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 14, pp. 8144–8149, 1999. View at Publisher · View at Google Scholar · View at Scopus
  91. P. K. Singal, A. Belló-Klein, F. Farahmand, and V. Sandhawalia, “Oxidative stress and functional deficit in diabetic cardiomyopathy,” Advances in Experimental Medicine and Biology, vol. 498, pp. 213–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. L. E. Wold, A. F. Ceylan-Isik, and J. Ren, “Oxidative stress and stress signaling: menace of diabetic cardiomyopathy,” Acta Pharmacologica Sinica, vol. 26, no. 8, pp. 908–917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. D. Bandyopadhyay, A. Chattopadhyay, G. Ghosh, and A. G. Datta, “Oxidative stress-induced ischemic heart disease: protection by antioxidants,” Current Medicinal Chemistry, vol. 11, no. 3, pp. 369–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino, “Status of myocardial antioxidants in ischemia-reperfusion injury,” Cardiovascular Research, vol. 47, no. 3, pp. 446–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. A. González, M. A. Fortuño, R. Querejeta et al., “Cardiomyocyte apoptosis in hypertensive cardiomyopathy,” Cardiovascular Research, vol. 59, no. 3, pp. 549–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Li, I. Danelisen, A. Belló-Klein, and P. K. Singal, “Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats,” Cardiovascular Research, vol. 46, no. 3, pp. 523–530, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Condorelli, C. Morisco, G. Stassi et al., “Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat,” Circulation, vol. 99, no. 23, pp. 3071–3078, 1999. View at Publisher · View at Google Scholar · View at Scopus
  98. M. H. V. M. Jacob, M. R. N. Pontes, A. S. R. Araújo et al., “Aortic-banding induces myocardial oxidative stress and changes in concentration and activity of antioxidants in male Wistar rats,” Life Sciences, vol. 79, no. 23, pp. 2187–2193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Teiger, T.-V. Dam, L. Richard et al., “Apoptosis in pressure overload-induced heart hypertrophy in the rat,” The Journal of Clinical Investigation, vol. 97, no. 12, pp. 2891–2897, 1996. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Yan, S. F. Vatner, and D. E. Vatner, “Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 307, no. 10, pp. H1521–H1528, 2014. View at Publisher · View at Google Scholar
  101. W. Kolch, “Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions,” Biochemical Journal, vol. 351, no. 2, pp. 289–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. S.-O. Yoon, C.-H. Yun, and A.-S. Chung, “Dose effect of oxidative stress on signal transduction in aging,” Mechanisms of Ageing & Development, vol. 123, no. 12, pp. 1597–1604, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Lorenzini, M. Tresini, M. Mawal-Dewan et al., “Role of the Raf/MEK/ERK and the PI3K/Akt(PKB) pathways in fibroblast senescence,” Experimental Gerontology, vol. 37, no. 10-11, pp. 1149–1156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Hutter, Y. Yo, W. Chen et al., “Age-related decline in Ras/ERK mitogen-activated protein kinase cascade is linked to a reduced association between Shc and EGF receptor,” Journals of Gerontology—Series A. Biological Sciences and Medical Sciences, vol. 55, no. 3, pp. B125–B134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Torres, M. K. Francis, A. Lorenzini, M. Tresini, and V. J. Cristofalo, “Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts,” Experimental Cell Research, vol. 290, no. 2, pp. 195–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Meloche, K. Gopalbhai, B. G. Beatty, S. W. Scherer, and J. Pellerin, “Chromosome mapping of the human genes encoding the MAP kinase kinase MEK1 (MAP2K1) to 15q21 and MEK2 (MAP2K2) to 7q32,” Cytogenetics and Cell Genetics, vol. 88, no. 3-4, pp. 249–252, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. X. Zhen, K. Uryu, G. Cai, G. P. Johnson, and E. Friedman, “Age-associated impairment in brain MAPK signal pathways and the effect of caloric restriction in Fischer 344 rats,” Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 54, no. 12, pp. B539–B548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. R. A. Miller, G. Garcia, C. J. Kirk, and J. M. Witkowski, “Early activation defects in T lymphocytes from aged mice,” Immunological Reviews, vol. 160, pp. 79–90, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Tresini, A. Lorenzini, L. Frisoni, R. G. Allen, and V. J. Cristofalo, “Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast,” Experimental Cell Research, vol. 269, no. 2, pp. 287–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Ikeyama, G. Kokkonen, S. Shack, X.-T. Wang, and N. J. Holbrook, “Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities.,” The FASEB journal, vol. 16, no. 1, pp. 114–116, 2002. View at Google Scholar · View at Scopus
  112. M. A. Madsen, C.-C. Hsieh, W. H. Boylston, K. Flurkey, D. Harrison, and J. Papaconstantinou, “Altered oxidative stress response of the long-lived Snell dwarf mouse,” Biochemical & Biophysical Research Communications, vol. 318, no. 4, pp. 998–1005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. N. Elbourkadi, S. N. Austad, and R. A. Miller, “Fibroblasts from long-lived species of mammals and birds show delayed, but prolonged, phosphorylation of ERK,” Aging Cell, vol. 13, no. 2, pp. 283–291, 2014. View at Publisher · View at Google Scholar
  114. P. Fabrizio, L.-L. Liou, V. N. Moy et al., “SOD2 functions downstream of Sch9 to extend longevity in yeast,” Genetics, vol. 163, no. 1, pp. 35–46, 2003. View at Google Scholar · View at Scopus
  115. B. S. Mandavilli, J. H. Santos, and B. Van Houten, “Mitochondrial DNA repair and aging,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 509, no. 1-2, pp. 127–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. Zhao, K. K. Kiningham, S.-M. Lin, and D. K. St. Clair, “Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFκB pathways,” Antioxidants & Redox Signaling, vol. 3, no. 3, pp. 375–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  117. S. R. Plymate, K. H. Haugk, C. C. Sprenger et al., “Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1,” Oncogene, vol. 22, no. 7, pp. 1024–1034, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., “Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,” Science, vol. 303, no. 5666, pp. 2011–2015, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. D. A. Salih and A. Brunet, “FoxO transcription factors in the maintenance of cellular homeostasis during aging,” Current Opinion in Cell Biology, vol. 20, no. 2, pp. 126–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Sengupta, J. D. Molkentin, and K. E. Yutzey, “FoxO transcription factors promote autophagy in cardiomyocytes,” Journal of Biological Chemistry, vol. 284, no. 41, pp. 28319–28331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Barthel, D. Schmoll, and T. G. Unterman, “FoxO proteins in insulin action and metabolism,” Trends in Endocrinology and Metabolism, vol. 16, no. 4, pp. 183–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Li, J.-F. Chiu, B. T. Mossman, and N. K. Fukagawa, “Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats,” The Journal of Biological Chemistry, vol. 281, no. 52, pp. 40429–40439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  123. G. J. P. L. Kops, T. B. Dansen, P. E. Polderman et al., “Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress,” Nature, vol. 419, no. 6904, pp. 316–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  124. Z. Gerhart-Hines, J. E. Dominy Jr., S. M. Blättler et al., “The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD+,” Molecular Cell, vol. 44, no. 6, pp. 851–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. Z. Wang, V. Li, G. C. K. Chan et al., “Adult type 3 adenylyl cyclase-deficient mice are obese,” PLoS ONE, vol. 4, no. 9, Article ID e6979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. T. Onda, Y. Hashimoto, M. Nagai et al., “Type-specific regulation of adenylyl cyclase: selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms,” The Journal of Biological Chemistry, vol. 276, no. 51, pp. 47785–47793, 2001. View at Google Scholar · View at Scopus
  127. N. Defer, M. Best-Belpomme, and J. Hanoune, “Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase,” The American Journal of Physiology—Renal Physiology, vol. 279, no. 3, pp. F400–F416, 2000. View at Google Scholar · View at Scopus
  128. T. Tang, N. C. Lai, H. K. Hammond et al., “Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice,” Journal of the American College of Cardiology, vol. 55, no. 14, pp. 1476–1486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Tang, M. H. Gao, N. C. Lai et al., “Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling,” Circulation, vol. 117, no. 1, pp. 61–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. T. Takahashi, T. Tang, N. C. Lai et al., “Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction,” Circulation, vol. 114, no. 5, pp. 388–396, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. N. C. Lai, T. Tang, M. H. Gao et al., “Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice,” Journal of the American College of Cardiology, vol. 51, no. 15, pp. 1490–1497, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. D. M. Roth, H. Bayat, J. D. Drumm et al., “Adenylyl cyclase increases survival in cardiomyopathy,” Circulation, vol. 105, no. 16, pp. 1989–1994, 2002. View at Publisher · View at Google Scholar · View at Scopus
  133. D. M. Roth, M. H. Gao, N. C. Lai et al., “Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy,” Circulation, vol. 99, no. 24, pp. 3099–3102, 1999. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Guellich, S. Gao, C. Hong et al., “Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 3, pp. H707–H712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. G. Lappas, G. B. Daou, and M. B. Anand-Srivastava, “Oxidative stress contributes to the enhanced expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats,” Journal of Hypertension, vol. 23, no. 12, pp. 2251–2261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. C. M. Tan, S. Xenoyannis, and R. D. Feldman, “Oxidant stress enhances adenylyl cyclase activation,” Circulation Research, vol. 77, no. 4, pp. 710–717, 1995. View at Publisher · View at Google Scholar · View at Scopus
  137. S. D. Rees, M. Z. I. Hydrie, J. P. O'Hare et al., “Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes,” PLoS ONE, vol. 6, no. 9, Article ID e24710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Iwatsubo, S. Minamisawa, T. Tsunematsu et al., “Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40938–40945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Iwatsubo, C. Bravo, M. Uechi et al., “Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 12, pp. H2622–H2628, 2012. View at Publisher · View at Google Scholar · View at Scopus